进行性家族性肝内胆汁淤积症3型一家系2例报告

李爱芹; 董漪; 徐志强; 王福川; 王丽旻; 闫建国; 曹丽丽; 王璞; 张敏

doi:10.3969/j.issn.1001-5256.2020.07.032

进行性家族性肝内胆汁淤积症3型一家系2例报告

DOI: 10.3969/j.issn.1001-5256.2020.07.032

中国人民解放军总医院第五医学中心青少年肝病诊疗与研究中心

基金项目:

首都临床特色应用研究(Z181100001718030)；

详细信息

中图分类号: R575
计量
- 文章访问数: 847
- HTML全文浏览量: 18
- PDF下载量: 140
- 被引次数: 0
出版历程
- 出版日期: 2020-07-20

Progressive familial intrahepatic cholestasis type 3: A report of two cases in one pedigree

Pediatric Liver Disease Treatment and Research Center,The Fifth Medical Center of Chinese PLA General Hospital

Research funding:

摘要

摘要: <正>进行性家族性肝内胆汁淤积症（progressive familial intrahepatic cholestasis,PFIC）是一组婴儿或儿童期起病,以严重肝内胆汁淤积及皮肤瘙痒为主要特征,在儿童期或者青春期可因肝衰竭而导致死亡的罕见常染色体隐性遗传性疾病。目前确切发病率尚无报道,估计为1/50 000～1/100 000[1]。PFIC共分6型,是我国儿童慢性胆汁淤积的重要原因之一。其中,1、2、4、5、6型的血清Y-GGT特征性降低或正常,而由ABCB4基因突
- 遗传性疾病,先天性 /
- 胆汁淤积,肝内 /
- 儿童
- genetic diseases,inborn /
- cholestasis,intrahepatic /
- child

HTML全文

参考文献(15)

[1]FREDERICK JS,SHIKHA SS,BENJAMIN LS.Familial hepatocellular cholestasis//Frederick JS,Ronald JS,William FB.Liver disease in children[M].4th ed,New York:Cambridge University Press,2014:199-215．

[2]WANG JS,LI LT.Advances in the study of familial intrahepatic cholestasis[J].Chin J Appl Clin Pediatr,2018,33(19):1451-1454．

[3]DAVIT-SPRAUL A,GONZALES E,BAUSSAN C,et al.Progressive familial intrahepatic cholestasis[J].Orphanet J Rare Dis,2009,4:1．

[4]GISSEN P,ARIAS IM.Structural and functional hepatocyte polarity and liver disease[J].J Hepatol,2015,63(4):1023-1037．

[5]YAN XM,HUANG ZH.Familial intranepatic cholestasis[J].J Clin Pediatr,2011,29(3):293-296．

[6]MOROTTI RA,SUCHY FJ,MAGID MS.Progressive familial intrahepatic cholestasis(PFIC)type 1,2,and 3:A review of the liver pathology findings[J].Semin Liver Dis,2011,31(1):3-10．

[7]SCHATZ SB,JNGST C,KEITEL-ANSELMO V,et al.Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset[J].Hepatol Commun,2018,2(5):504-514．

[8]BOGA S,JAIN D,SCHILSKY ML.Presentation of progressive familial intrahepatic cholestasis type 3 mimicking wilson disease:molecular genetic diagnosis and response to treatment[J].Pediatr Gastroenterol Hepatol Nutr,2015,18(3):202-208．

[9]KNISELY AS,STRANTNIEKS S,SCHEIMANN AO,et al.Bile salt export pump(BSEP)deficiency is a significant risk factor for both pediatric and adult hepatobiliary malignancy[J].Hepatology,2005,42(4):380A-381A．

[10]GUDBJARTSSON DF,HELGASON H,GUDJONSSON SA,et al.Large-scale whole-genome sequencing of the Icelandic population[J].Nat Genet,2015,47(5):435-444．

[11]MHATRE S,WANG Z,NAGRANI R,et al.Common genetic variation and risk of gallbladder cancer in India:A case-control genomewide association study[J].Lancet Oncol,2017,18(4):535-544．

[12]MIETHKE AG,ZHANG W,SIMMONS J,et al.Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice[J].Hepatology,2016,63(2):512-523．

[13]REICHERT MC,LAMMERT F.ABCB4 gene aberrations in human liver disease:An evolving spectrum[J].Semin Liver Dis,2018,38(4):299-307．

[14]SIEW SM,CUNNINGHAM SC,ZHU E,et al.Prevention of cholestatic liver diseaseand reduced tumorigenicity in a murine model of PF-IC Type 3 using hybrid AAV-piggy Bac gene therapy[J].Hepatology,2019,70(6):2047-2061．

[15]ARONSON SJ,BAKKER RS,SHI X,et al.Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice[J].J Hepatol,2019,71(1):153-162.

施引文献

资源附件(0)

访问统计